FI920670A0 - Polypeptidanaloger av apolipoprotein e, diagnostiska system och metoder daer dessa analoger anvaends. - Google Patents

Polypeptidanaloger av apolipoprotein e, diagnostiska system och metoder daer dessa analoger anvaends.

Info

Publication number
FI920670A0
FI920670A0 FI920670A FI920670A FI920670A0 FI 920670 A0 FI920670 A0 FI 920670A0 FI 920670 A FI920670 A FI 920670A FI 920670 A FI920670 A FI 920670A FI 920670 A0 FI920670 A0 FI 920670A0
Authority
FI
Finland
Prior art keywords
analoger
polypeptidal
anvaends
daer
dessa
Prior art date
Application number
FI920670A
Other languages
English (en)
Finnish (fi)
Inventor
Cheryl A Dyer
Linda K Curtiss
Richard Smith
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/395,732 external-priority patent/US5177189A/en
Priority claimed from US07/485,158 external-priority patent/US5182364A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI920670A0 publication Critical patent/FI920670A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Connection Of Plates (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI920670A 1989-08-18 1992-02-17 Polypeptidanaloger av apolipoprotein e, diagnostiska system och metoder daer dessa analoger anvaends. FI920670A0 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/395,732 US5177189A (en) 1989-08-18 1989-08-18 Polypeptide analogs of Apolipoprotein E
US07/485,158 US5182364A (en) 1990-02-26 1990-02-26 Polypeptide analogs of apolipoprotein E
US07/540,363 US5168045A (en) 1989-08-18 1990-06-18 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
PCT/US1990/004651 WO1991002751A1 (en) 1989-08-18 1990-08-17 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs

Publications (1)

Publication Number Publication Date
FI920670A0 true FI920670A0 (fi) 1992-02-17

Family

ID=27410184

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920670A FI920670A0 (fi) 1989-08-18 1992-02-17 Polypeptidanaloger av apolipoprotein e, diagnostiska system och metoder daer dessa analoger anvaends.

Country Status (9)

Country Link
US (1) US5168045A (el)
EP (1) EP0487629A1 (el)
JP (1) JPH05501400A (el)
AU (1) AU648991B2 (el)
FI (1) FI920670A0 (el)
GR (1) GR1001065B (el)
IE (1) IE902992A1 (el)
PT (1) PT95030A (el)
WO (1) WO1991002751A1 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
ATE171192T1 (de) * 1992-06-12 1998-10-15 Innogenetics Nv Peptide und proteine, verfahren zur ihren herstellung und die verwendung als cholesterol- annehmer
ZA935879B (en) * 1992-08-12 1994-03-11 Bio Technology General Corp Method of inhibiting cell proliferation using apolipoprotein E.
ATE262592T1 (de) * 1992-10-13 2004-04-15 Univ Duke Verfahren zum nachweis der alzheimer krankheit
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
US20030077641A1 (en) * 1998-03-11 2003-04-24 Laskowitz Daniel T. Methods of suppressing microglial activation and systemic inflammatory responses
KR20220150995A (ko) 2008-11-10 2022-11-11 알닐람 파마슈티칼스 인코포레이티드 치료제 운반용 신규 지질 및 조성물
ITTO20080894A1 (it) * 2008-12-02 2010-06-03 Bioindustry Park Del Canavese S P A Uso dell'aptoglobina, peptidi leganti l'aptoglobina, polimeri contenenti gli stessi e loro uso
EP3243504A1 (en) 2009-01-29 2017-11-15 Arbutus Biopharma Corporation Improved lipid formulation
EP2406376A1 (en) 2009-03-12 2012-01-18 Alnylam Pharmaceuticals, Inc. LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
SG10201402054UA (en) 2009-05-05 2014-09-26 Muthiah Manoharan Lipid compositions
TR201811076T4 (tr) 2009-06-10 2018-08-27 Arbutus Biopharma Corp Geliştirilmiş lipit formulasyonu.
US20120107243A1 (en) 2009-07-14 2012-05-03 Mayo Foundation For Medical Education And Research Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier
EP2810643A3 (en) 2009-08-14 2015-03-11 Alnylam Pharmaceuticals Inc. Lipid formulated compositions and mehods for inhibiting expression of a gene from the ebola virus
EP2509636B1 (en) 2009-12-07 2017-07-19 Arbutus Biopharma Corporation Compositions for nucleic acid delivery
CA2784568A1 (en) 2009-12-18 2011-06-23 Martin A. Maier Lipid particles for delivery of nucleic acids
US20130156845A1 (en) 2010-04-29 2013-06-20 Alnylam Pharmaceuticals, Inc. Lipid formulated single stranded rna
WO2011141704A1 (en) 2010-05-12 2011-11-17 Protiva Biotherapeutics, Inc Novel cyclic cationic lipids and methods of use
JP2013527856A (ja) 2010-05-12 2013-07-04 プロチバ バイオセラピューティクス インコーポレイティッド 陽イオン性脂質およびその使用方法
CN103096875B (zh) 2010-06-03 2016-08-17 阿尔尼拉姆医药品有限公司 用于递送活性剂的生物可降解脂质
WO2012016188A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
WO2012016184A2 (en) 2010-07-30 2012-02-02 Alnylam Pharmaceuticals, Inc. Methods and compositions for delivery of active agents
US9339513B2 (en) 2010-11-09 2016-05-17 Alnylam Pharmaceuticals, Inc. Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
DK2663548T3 (en) 2011-01-11 2017-07-24 Alnylam Pharmaceuticals Inc PEGYLED LIPIDS AND THEIR USE FOR PHARMACEUTICAL SUPPLY
EP2760477B1 (en) 2011-09-27 2018-08-08 Alnylam Pharmaceuticals, Inc. Di-aliphatic substituted pegylated lipids
WO2014011908A1 (en) 2012-07-11 2014-01-16 Esperion Therapeutics, Inc. Apolipoprotein mixtures
US10072065B2 (en) 2015-08-24 2018-09-11 Mayo Foundation For Medical Education And Research Peptide-mediated delivery of immunoglobulins across the blood-brain barrier
CN112375138B (zh) * 2020-11-13 2022-12-13 中元汇吉生物技术股份有限公司 一种重组载脂蛋白e和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483793A (en) * 1982-10-04 1984-11-20 The Regents Of The University Of California Dimeric oligopeptides as heptenic epitopic sites for hepatitis
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
SE448324B (sv) * 1985-09-27 1987-02-09 Pharmacia Ab Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner
US4828986A (en) * 1986-09-29 1989-05-09 Scripps Clinic And Research Foundation Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
ZA884504B (en) * 1987-06-29 1989-03-29 Merrell Dow Pharma Immunosuppressant peptides

Also Published As

Publication number Publication date
AU648991B2 (en) 1994-05-12
PT95030A (pt) 1991-04-18
GR1001065B (el) 1993-04-28
GR900100621A (en) 1991-12-30
WO1991002751A1 (en) 1991-03-07
IE902992A1 (en) 1991-02-27
EP0487629A1 (en) 1992-06-03
AU6337090A (en) 1991-04-03
US5168045A (en) 1992-12-01
JPH05501400A (ja) 1993-03-18

Similar Documents

Publication Publication Date Title
FI920670A0 (fi) Polypeptidanaloger av apolipoprotein e, diagnostiska system och metoder daer dessa analoger anvaends.
FI900130A (fi) Flytande detergentkomposition innehaollande enzymer och enzymstabiliserande system.
NO900746L (no) System for omraade-begrensning.
FI895317A0 (fi) System foer byggklotsar.
FI905946A (fi) System foer aostadkommande av ett genombrottsstaelle i ett minfaelt.
FI920800A0 (fi) En method och en anordning foer olineaera medelvaerdeskompenserade maetningar.
FI904823A0 (fi) Karboxylsyraestrar, naemnda karboxylsyraestrar innehaollande flytande kompositioner och foerfaranden foer smoerjning av metalldelar.
FI900033A0 (fi) Foerfarande och system foer applicering av en maerkning pao ett underlag, speciellt pao en maolad list intill och omkring en vindruteskiva.
FI902686A0 (fi) Foerfarande foer framstaellning av dubbelsidigt belagda bandtransportoerer, i synnerhet foer pappers- och textilmaskiner, och anordning foer utfoering av foerfarandet.
FI890785A0 (fi) System av undertrycksmunstycken avsett foer behandling av roerliga aemnesbanor.
FI900682A0 (fi) Verktyg, paosaettningsmedel och ringanordning foer kedjor foer foerhindrande av glidning.
NO893260L (no) Forskalingssystem.
FI905753A (fi) Biologiskt nedbrytbara, vattenloesliga polykarboxylsyrakopolymerer, kompositioner innehaollande dylika kopolymerer, och foerfaranden foer anvaendning av saodana polymerer.
FI904830A0 (fi) Foerfarande foer foerhindrande av bakterieadhesion och kontroll av biologisk nedsmutsning i vattenhaltiga system.
FI895997A (fi) Vaeggkonstruktion, saett och anordning foer bearbetning av vaeggstockar.
FI910249A0 (fi) System foer saendning och mottagning av fjaerrstyrningssignaler.
FI893718A0 (fi) Foerfarande och system foer resning av stolpar.
FI893227A0 (fi) System foer inmatning, lagring, foerskjutning och avlaegsning av rullpallar.
FI892412A0 (fi) System foer mekanisering av fraonkoppling, parkering, kassettering och tillkoppling av en kassettslaepvagn.
FI890736A (fi) System foer tagning av mellantider.
FI893152A (fi) System foer dosering av utsprutad vaetska.
FI893940A0 (fi) System foer maetning av braeders vankant.
FI900792A0 (fi) System foer dosering av utsprutad vaetska.
FI894915A0 (fi) System foer kontrollmaetning av braeders kantning.
FI894695A (fi) Digitalt system foer reglering av stroemmen i en elektrisk motor.

Legal Events

Date Code Title Description
FD Application lapsed